Entity · moving across domains

FDA

FDA — U.S. Food and Drug Administration. The U.S. regulator that approves drugs, medical devices, and food safety.

As of 9 Oct 2026Last evidence 8 Oct 2026

What is happening now

  • FDA approves atezolizumab in combination with chemotherapy for Stage III mismatch repair deficient colon cancer

    Reported claim · first reported 8 Oct 2026 · 1 claim · best-carried claim: 3 separate publishers

  • FDA Advisory No.2026-1507 || Public Health Warning Against the Purchase and Use of the Unnotified Medical Device Product “UNBRANDED ARM SLING

    Reported claim · first reported 7 Oct 2026 · 1 claim · best-carried claim: 1 separate publisher

  • FDA Seeks Public Input On Psychedelic Research Involving Ibogaine

    Reported claim · first reported 6 Oct 2026 · 1 claim · best-carried claim: 2 separate publishers

  • US FDA delays review of Novo hemophilia drug denecimig over manufacturing issue

    Reported claim · first reported 5 Oct 2026 · 1 claim · best-carried claim: 2 separate publishers

  • FDA to Highlight Aging, Longevity Medicine in Planned FARS Updates

    Reported claim · first reported 3 Oct 2026 · 1 claim · best-carried claim: 2 separate publishers

All 8 events and claims involving FDA

What changed

  • Attention Rising: 171 mentions on 9 Oct 2026, against 98 on 18 Sept 2026 (+74%).
  • State Changes between snapshots: cannot measure, no state history is kept for FDA yet.
  • Claims 1 claim first reported since 8 Oct 2026.

How well we know this

1,883 documents · 185 publishers · 50% contain a typed assertion · last evidence 8 Oct 2026

  • Gap: assertion coverage 0.502: about 50% of mentions carry no typed assertion
  • Gap: 4 receipts withheld: no source link (the same rule the topic record applies)

In this snapshot’s daily coverage:

Reported alongside FDA

Names most often reported alongside it; bigger circles and heavier lines mean more shared documents. A dashed circle has no page of its own yet.

United StatesAIFda-Approved
  • Drug Administration · 691 shared documents · no page of its own yet
  • Studie · 293 shared documents · no page of its own yet
  • U.s. Food · 267 shared documents · no page of its own yet
  • Clinical Trial · 260 shared documents · no page of its own yet
  • United States · 240 shared documents
  • Clinical Trials · 222 shared documents · no page of its own yet
  • AI · 221 shared documents
  • Public Health · 164 shared documents · no page of its own yet
  • Fda-Approved · 160 shared documents
  • Drug Development · 139 shared documents · no page of its own yet

Story momentum

Rising

Daily mentions +403% from 25 Aug 2026 to 9 Oct 2026, between 10 and 171 a day

How often tracked coverage mentions FDA, day by day.

Market price, cited

Not priced yet

No open prediction market prices a question materially about FDA yet. Ask about FDA

No market price on file: no prediction market prices a question about this name yet

Coverage volume and market price are separate measures.

On the desk: Health & Bio Desk

For developers

This page is also an object: GET https://sigb.ai/api/v1/node/e/1ccaf7a7b68e32af55cbc6a4 returns the same record as sb.node.v1. Or call the get_entity MCP tool at https://sigb.ai/api/mcp with name fda.

{
  "name": "fda",
  "label": "FDA",
  "asOf": "2026-10-09",
  "mentions": 171,
  "domains": 35,
  "node": {
    "id": "sb:e/1ccaf7a7b68e32af55cbc6a4",
    "schema": "sb.node.v1",
    "rest": "https://sigb.ai/api/v1/node/e/1ccaf7a7b68e32af55cbc6a4",
    "knowledgeCutoff": "2026-10-09T23:33:39.923351+00:00",
    "snapshot": "this deploy's committed data files (commit not exposed in this runtime)"
  },
  "coverageTrend": "rising",
  "whereFrom": {
    "level": "counts",
    "label": "171 mentions across 35 domains",
    "children": [
      {
        "level": "reports",
        "label": "6 reports drawn on this page, each with its link",
        "children": {
          "count": 6,
          "unfold": "expand=+1"
        }
      },
      {
        "level": "domains",
        "label": "35 coverage domains",
        "children": {
          "count": 18,
          "unfold": "expand=+1"
        }
      },
      {
        "level": "not shown",
        "label": "The other 165 mentions",
        "edge": "counted daily from tracked coverage; single mentions are not listed one by one"
      }
    ]
  }
}

The figures on this page, as data. The tool returns the full entity record.

Events involving FDA

Most-reported first, then newest. Registered events come from the event record; reported events are groups of claims about one occurrence. Claims are grouped when they were first reported within 2 days of each other and either name at least 2 of the same people, places or things besides this one, or share at least 25% of their wording. Each claim keeps its own record.

  • FDA approves atezolizumab in combination with chemotherapy for Stage III mismatch repair deficient colon cancer

    Reported claim · first reported 8 Oct 2026 · 1 claim · best-carried claim: 3 separate publishers

    corroborated

  • FDA Advisory No.2026-1507 || Public Health Warning Against the Purchase and Use of the Unnotified Medical Device Product “UNBRANDED ARM SLING

    Reported claim · first reported 7 Oct 2026 · 1 claim · best-carried claim: 1 separate publisher

    single source

  • FDA Seeks Public Input On Psychedelic Research Involving Ibogaine

    Reported claim · first reported 6 Oct 2026 · 1 claim · best-carried claim: 2 separate publishers

    corroborated

  • US FDA delays review of Novo hemophilia drug denecimig over manufacturing issue

    Reported claim · first reported 5 Oct 2026 · 1 claim · best-carried claim: 2 separate publishers

    corroborated

  • FDA to Highlight Aging, Longevity Medicine in Planned FARS Updates

    Reported claim · first reported 3 Oct 2026 · 1 claim · best-carried claim: 2 separate publishers

    corroborated

  • 2026 fda approved weight loss drug retatrutide approval status

    Reported claim · first reported 3 Oct 2026 · 1 claim · best-carried claim: 2 separate publishers

    corroborated

  • With FDA approval, Lilly’s BTK drug Jaypirca enters first-line CLL

    Reported claim · first reported 3 Oct 2026 · 1 claim · best-carried claim: 2 separate publishers

    corroborated

  • A heart valve that grows up with the patient wins FDA approval

    Reported claim · first reported 3 Oct 2026 · 1 claim · best-carried claim: 2 separate publishers

    corroborated

Walk the record from FDA

Open where it comes from, follow a claim or a related name, and use the trail to come back. Every step says what it is, how it stands and when. Machines read the same record.

FDA

Entity.

Evidence
1,883 documents · 185 separate publishers · a mention shows the name is in use, not that any claim about it is true
Standing
A name from our starting list; its record is kept up to date automatically from coverage
Time
first seen 6 Apr 2026, last seen 8 Oct 2026
Measured
50% of mentions say something specific about it; the rest only name it
As of
9 Oct 2026
18 links from here

Who it moves with: the 10 names are in the map above.

What is claimed about it (8)

  • Corroborated: Reported by three or more sources that did not copy each other.
  • Reported by two: Reported by two sources that did not copy each other.
  • Single source: Reported by one source so far.

Situations it is named in (0)

none on file at this cutoff

For machines: this record as JSON

Watch this

What the coverage says

Recent reporting that names FDA, newest first. Open any row to follow it to the original article.

What it connects to

Related records.

Ask about FDAWatch FDA

Story momentum counts mentions in tracked coverage. Prices are the market’s own, cited with the venue. Informational only, not advice. As of 9 Oct 2026.